Document resource
We read with interest Gisbert et al’s report of EXIT, a randomised controlled trial (RCT) withdrawing anti-TNF in patients with inflammatory bowel disease (IBD), while continuing immunomodulators.1
Annotated abstract
Withdrawal of antitumour necrosis factor in patients with inflammatory bowel disease in remission: a randomised placebo-controlled clinical trial of GETECCU
gutjnl · 2025-09-08 · canonical JSON source